Intriguingly, patients with lower CDC45 expression exhibited a more unfavorable survival prognosis in GC, consistent with findings in colorectal cancer (Hu et al., 2019), cervical squamous cell carcinoma and endocervical adenocarcinoma (Lu et al., 2022). Here, CDC45 is linked to colorectal cancer.